Wong N, Lai P, Pang E, Fung L F, Sheng Z, Wong V, Wang W, Hayashi Y, Perlman E, Yuna S, Lau J W, Johnson P J
Department of Clinical Oncology, Sir Y. K. Pao Centre for Cancer, The Chinese University of Hong Kong, Shatin, New Territories, Special Administrative Region.
Clin Cancer Res. 2000 Oct;6(10):4000-9.
We sought to assess whether genetic abnormalities in hepatocellular carcinoma differed in geographic locations associated with different risk factors. Comparative genomic hybridization (CGH) was applied to the genome-wide chromosomal analysis in 83 tumor samples from four different geographic origins. Samples were obtained from regions that differed in aflatoxin exposure: China (Hong Kong with low aflatoxin exposure and Shanghai with moderate aflatoxin exposure), Japan, and the United States (negligible aflatoxin exposure). Cases from Hong Kong and Shanghai were all hepatitis B virus (HBV) related, those from Japan were hepatitis C virus related, and those from the United States were HBV negative. In parallel, the mutational pattern of the whole p53 gene (exons 1-11) was also investigated in these cases. CGH revealed a complex pattern of chromosomal gains and losses, with the commonest aberration in each geographic location being chromosome 1q copy number gain (38-60%). Shanghai cases displayed the highest number of total aberrations per sample, with significant copy losses on 4q (75%), 8p (70%), and 16q (65%). Hepatitis C virus-related samples from Japan had a characteristically high incidence of 11q13 gain. p53 mutation(s) was detected in 23% of Hong Kong cases, 40% of Shanghai, 31% of Japan, but only 6% of the United States cases. The "aflatoxin-associated" codon 249 mutation was, however, identified only in samples from China (13% Hong Kong and 20% Shanghai). This finding, together with the highly aberrant pattern of genetic changes detected in the Shanghai series, is suggestive of the genotoxic effects of aflatoxin being more broadly based. It is also likely that there is a synergistic effect of HBV infection and high aflatoxin exposure in promoting hepatocellular carcinoma development. It appears from our CGH study that individual risk factors are indeed associated with distinct genetic aberrations, although changes in 1q gain appear common to all.
我们试图评估肝细胞癌的基因异常在与不同风险因素相关的地理位置上是否存在差异。比较基因组杂交(CGH)被应用于对来自四个不同地理区域的83个肿瘤样本进行全基因组染色体分析。样本取自黄曲霉毒素暴露情况不同的地区:中国(低黄曲霉毒素暴露的香港和中等黄曲霉毒素暴露的上海)、日本和美国(可忽略不计的黄曲霉毒素暴露)。香港和上海的病例均与乙型肝炎病毒(HBV)相关,日本的病例与丙型肝炎病毒相关,而美国的病例HBV呈阴性。同时,还对这些病例中整个p53基因(外显子1 - 11)的突变模式进行了研究。CGH揭示了复杂的染色体增减模式,每个地理位置最常见的畸变是1q染色体拷贝数增加(38% - 60%)。上海的病例每个样本的总畸变数量最多,4q(75%)、8p(70%)和16q(65%)有明显的拷贝数丢失。来自日本的丙型肝炎病毒相关样本11q13增加的发生率特别高。在香港病例中检测到23%有p53突变,上海为40%,日本为31%,而美国病例中只有6%。然而,“黄曲霉毒素相关的”密码子249突变仅在中国的样本中被鉴定出来(香港为13%,上海为20%)。这一发现,连同在上海系列中检测到的高度异常的基因变化模式,提示黄曲霉毒素的遗传毒性作用基础更广泛。HBV感染和高黄曲霉毒素暴露在促进肝细胞癌发展中也可能存在协同作用。从我们的CGH研究来看,尽管1q增加的变化似乎在所有样本中都很常见,但个体风险因素确实与不同的基因畸变相关。